Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Bile duct adenocarcinoma
ADR ID BADD_A09547
ADR Hierarchy
09      Hepatobiliary disorders
09.04      Hepatobiliary neoplasms
09.04.02      Malignant hepatobiliary neoplasms
09.04.02.013      Bile duct adenocarcinoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.07      Hepatobiliary neoplasms malignant and unspecified
16.07.01      Bile duct neoplasms malignant
16.07.01.003      Bile duct adenocarcinoma
Description Not Available
MedDRA Code 10004585
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bile duct adenocarcinoma | Bile duct adenocarcinoma non-resectable | Bile duct adenocarcinoma recurrent | Bile duct adenocarcinoma resectable | Bile duct clear cell adenocarcinoma | Bile duct clear cell adenocarcinoma non-resectable | Bile duct clear cell adenocarcinoma recurrent | Bile duct clear cell adenocarcinoma resectable | Bile duct mucinous adenocarcinoma | Bile duct mucinous adenocarcinoma non-resectable | Bile duct mucinous adenocarcinoma recurrent | Bile duct mucinous adenocarcinoma resectable | Bile duct papillary adenocarcinoma | Bile duct papillary adenocarcinoma non-resectable | Bile duct papillary adenocarcinoma recurrent | Bile duct papillary adenocarcinoma resectable | Bile duct signet-ring cell carcinoma | Bile duct signet-ring cell carcinoma recurrent
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02029Sitagliptin0.000080%
The 1th Page    1    Total 1 Pages